Prescription Drug Name:

LOSARTAN POTASSIUM

ID:

25fe6b18-e409-4b17-e054-00144ff8d46c

Code:

34391-3

Boxed Warning


id: 26013282-48e6-583c-e054-00144ff8d46c
displayName: BOXED WARNING SECTION
FDA Article Code: 34066-1

fetal toxicity When pregnancy is detected, discontinue losartan potassium tablets as soon as possible.

Drugs that act directly on the rennin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS, Fetal Toxicity.

Description


id: 25ff3604-149d-1fc0-e054-00144ff88e88
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3

Clinical Pharmacology


id: 25ff4044-c3e9-053b-e054-00144ff8d46c
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1

Indications and Usage


id: 25ff4044-c3ed-053b-e054-00144ff8d46c
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9

Contraindications


id: 25ff4044-c3ef-053b-e054-00144ff8d46c
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3

Warnings


id: 25ff3604-14a0-1fc0-e054-00144ff88e88
displayName: WARNINGS SECTION
FDA Article Code: 34071-1

Precautions


id: 25ff4044-c3f1-053b-e054-00144ff8d46c
displayName: PRECAUTIONS SECTION
FDA Article Code: 42232-9

Adverse Reactions


id: 25ff4044-c3f3-053b-e054-00144ff8d46c
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4

Overdosage


id: 25ff4044-c3f7-053b-e054-00144ff8d46c
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5

Dosage and Administration


id: 25ff45f9-5da2-0644-e054-00144ff8d46c
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7

Package Label


id: 25ff45f9-5da5-0644-e054-00144ff8d46c
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4